Alberto Mate-Romero

Fuenlabrada, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Ultra-late recurrence of stage IA melanoma: a case report

Ultra-late recurrence of stage IA melanoma: a case report

Journal: Semergen

Published: November 05, 2025

Mowed-meadow pattern of the tongue.

Mowed-meadow pattern of the tongue.

Journal: BMJ case reports

Published: May 12, 2025

Anifrolumab for the treatment of cutaneous lupus erythematosus: a 10-case series.

Anifrolumab for the treatment of cutaneous lupus erythematosus: a 10-case series.

Journal: Clinical and experimental dermatology

Published: March 21, 2025

Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice.

Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice.

Journal: Actas dermo-sifiliograficas

Published: September 12, 2024

Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study.

Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study.

Journal: Actas dermo-sifiliograficas

Published: January 25, 2024

Neutrophilic eccrine hidradenitis as a clue to the diagnosis of Behçet's disease: Case report with excellent response to adalimumab.

Neutrophilic eccrine hidradenitis as a clue to the diagnosis of Behçet's disease: Case report with excellent response to adalimumab.

Journal: The Australasian journal of dermatology

Published: October 17, 2023

Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting.

Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting.

Journal: International journal of dermatology

Published: December 28, 2022

Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population.

Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population.

Journal: The Australasian journal of dermatology

Published: November 07, 2022

Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients.

Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients.

Journal: Dermatologic therapy

Published: August 23, 2022

Facial hyperpigmentation with singular dermoscopic findings.

Facial hyperpigmentation with singular dermoscopic findings.

Journal: International journal of dermatology

Published: June 16, 2022

An Unexpected Dermatophyte? Two Remarkable Cases of Tinea Barbae by Trichophyton benhamiae.

An Unexpected Dermatophyte? Two Remarkable Cases of Tinea Barbae by Trichophyton benhamiae.

Journal: Dermatology practical & conceptual

Published: June 13, 2022

Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting.

Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting.

Journal: Dermatologic therapy

Published: May 17, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026